EA202092753A1 - BISPECIFIC ANTIBODIES TO BCMA / CD3 AND GPRDC5D / CD3 FOR USE IN THE TREATMENT OF CANCER - Google Patents
BISPECIFIC ANTIBODIES TO BCMA / CD3 AND GPRDC5D / CD3 FOR USE IN THE TREATMENT OF CANCERInfo
- Publication number
- EA202092753A1 EA202092753A1 EA202092753A EA202092753A EA202092753A1 EA 202092753 A1 EA202092753 A1 EA 202092753A1 EA 202092753 A EA202092753 A EA 202092753A EA 202092753 A EA202092753 A EA 202092753A EA 202092753 A1 EA202092753 A1 EA 202092753A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- bispecific antibodies
- bcma
- gprdc5d
- cancer
- Prior art date
Links
Abstract
Настоящая заявка относится к биспецифическим антителам, либо BCMA*CD3, либо GRRC5D*CD3. Биспецифические антитела предназначены для применения в лечении рефрактерных раковых заболеваний, особенно после предшествующего лечения антителом к CD38.This application relates to bispecific antibodies, either BCMA * CD3 or GRRC5D * CD3. Bispecific antibodies are intended for use in the treatment of refractory cancers, especially after prior treatment with an anti-CD38 antibody.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962842080P | 2019-05-02 | 2019-05-02 | |
PCT/IB2019/054033 WO2019220368A1 (en) | 2018-05-16 | 2019-05-15 | Bcma/cd3 and gprdc5d/cd3 bispecific antibodies for use in cancer therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202092753A1 true EA202092753A1 (en) | 2021-03-12 |
Family
ID=75262217
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202092754A EA202092754A1 (en) | 2019-05-02 | 2019-05-15 | METHODS FOR TREATING CANCER AND INCREASING THE EFFECTIVENESS OF THERAPEUTIC AGENTS REDIRECTING T-CELLS |
EA202092753A EA202092753A1 (en) | 2019-05-02 | 2019-05-15 | BISPECIFIC ANTIBODIES TO BCMA / CD3 AND GPRDC5D / CD3 FOR USE IN THE TREATMENT OF CANCER |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202092754A EA202092754A1 (en) | 2019-05-02 | 2019-05-15 | METHODS FOR TREATING CANCER AND INCREASING THE EFFECTIVENESS OF THERAPEUTIC AGENTS REDIRECTING T-CELLS |
Country Status (1)
Country | Link |
---|---|
EA (2) | EA202092754A1 (en) |
-
2019
- 2019-05-15 EA EA202092754A patent/EA202092754A1/en unknown
- 2019-05-15 EA EA202092753A patent/EA202092753A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA202092754A1 (en) | 2021-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JOP20200292A1 (en) | Bcma/cd3 and gprdc5d/cd3 bispecific antibodies for use in cancer therapy | |
PH12019502640A1 (en) | Antibodies specific for flt3 and their uses | |
MX2020012797A (en) | Anti-pvrig/anti-tigit bispecific antibodies and methods of use. | |
CR20200467A (en) | Anti-cd25 for tumour specific cell depletion | |
PH12020500671A1 (en) | Antibodies specific for gucy2c and uses thereof | |
PH12019500550A1 (en) | Bi specific anti-muc16-cd3 antibodies and anti-muc16 drug conjugates | |
MX2018010473A (en) | Combination therapy with anti-cd73 antibodies. | |
JOP20200300A1 (en) | Il-11ra antibodies | |
PH12020552221A1 (en) | Anti-pd-1 antibodies and uses thereof | |
EA201691824A1 (en) | ANTIBODIES AGAINST EGFRVIII AND THEIR APPLICATIONS | |
MX2021015888A (en) | Fusion of an antibody binding cea and 4-1bbl. | |
MX2021000392A (en) | Anti-mesothelin antibodies. | |
MX2021004732A (en) | Heavy chain antibodies binding to cd38. | |
MX2019013753A (en) | Anti-folr1 immunoconjugates and anti-pd-1 antibody combinations. | |
PH12020552006A1 (en) | Antibodies specific for cd3 and uses thereof | |
EA201992316A1 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSTIC OF PROSTATE CANCER | |
MX2021003673A (en) | Anti-human vsig4 antibodies and uses thereof. | |
PH12020551968A1 (en) | Anti-sez6 antibody drug conjugates and methods of use | |
MX2019000963A (en) | Glucocorticoid-induced tumor necrosis factor receptor (gitr) antibodies and methods of use thereof. | |
PH12020551451A1 (en) | Anti-cd25 for tumour specific cell depletion | |
EA202092753A1 (en) | BISPECIFIC ANTIBODIES TO BCMA / CD3 AND GPRDC5D / CD3 FOR USE IN THE TREATMENT OF CANCER | |
MX2021001604A (en) | Cancer treatment with an antibody. | |
EA202191605A1 (en) | ANTIBODIES TO PERIOSTIN AND THEIR APPLICATION | |
EA202092947A1 (en) | ANTI-PVRIG / ANTI-TIGIT BISPECIFIC ANTIBODIES AND METHODS OF THEIR APPLICATION | |
MX2022008745A (en) | ANTI-NKp30 ANTIBODIES AND METHODS OF USE. |